Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acid Treatment
40%
Apoptosis
20%
Cell-mediated
20%
Conjugate Formation
20%
Current Therapies
20%
Cytostatic/cytotoxic Effect
100%
Cytotoxic T Lymphocytes
20%
Downmodulation
20%
Enhancement Effect
20%
G1 Arrest
20%
Her2neu
20%
Immunomodulatory Effect
100%
Lymphocytes
20%
Lysis
20%
Melanoma Cells
20%
Melanoma Patients
20%
MHC Class I
20%
Morphological Changes
20%
Natural Killer Cells
20%
New Targets
20%
New Treatment Options
20%
NK Cell Immunotherapy
20%
Oncogene Expression
20%
P21 Protein
20%
P27 Protein
20%
P53 Protein
20%
Protein Level
20%
Proto-oncogene
20%
Retinoic Acid
100%
Retinoids
40%
T Cell-based Immunotherapy
20%
T Cells
20%
Uveal Melanoma
40%
Uveal Melanoma Cells
100%
Uveal Metastasis
20%
Immunology and Microbiology
Cytotoxic T Cell
25%
G1 Phase Cell Cycle Checkpoint
25%
Immunotherapy
25%
Lymphocyte
25%
Melanoma Cell
100%
MHC Class I
25%
Morphology
25%
Natural Killer Cell
50%
P53
25%
Programmed Cell Death
25%
Proto Oncogene
25%
T Cell
25%
Uveal Melanoma Cell Line
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cytostatic
100%
Immunotherapy
12%
Metastatic Melanoma
12%
Protein P21
12%
Protein P27
12%
Protein P53
12%
Retinoic Acid
100%
Retinoid
25%
Uvea Melanoma
100%
Nursing and Health Professions
Immunotherapy
12%
Metastatic Melanoma
12%
Protein P21
12%
Protein P27
12%
Protein P53
12%
Retinoic Acid
100%
Retinoid
25%
Uvea Melanoma
100%